Geode Capital Management LLC Sells 11,112 Shares of Cibus, Inc. (NASDAQ:CBUS)

Geode Capital Management LLC decreased its position in Cibus, Inc. (NASDAQ:CBUSFree Report) by 3.0% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 364,923 shares of the company’s stock after selling 11,112 shares during the quarter. Geode Capital Management LLC owned 1.38% of Cibus worth $1,190,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. Bank of New York Mellon Corp acquired a new position in Cibus in the second quarter valued at about $529,000. Rhumbline Advisers acquired a new position in shares of Cibus in the 2nd quarter worth approximately $221,000. Old West Investment Management LLC grew its position in Cibus by 3.6% during the 2nd quarter. Old West Investment Management LLC now owns 53,247 shares of the company’s stock worth $524,000 after acquiring an additional 1,868 shares during the last quarter. Squarepoint Ops LLC acquired a new stake in Cibus during the 2nd quarter valued at $214,000. Finally, Armistice Capital LLC bought a new position in Cibus in the 2nd quarter valued at $5,083,000. Institutional investors and hedge funds own 33.81% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on CBUS. HC Wainwright restated a “buy” rating and set a $25.00 target price on shares of Cibus in a report on Monday, November 11th. Alliance Global Partners decreased their price objective on shares of Cibus from $25.00 to $23.50 and set a “buy” rating on the stock in a report on Tuesday, September 24th. Finally, Canaccord Genuity Group reiterated a “buy” rating and set a $20.00 target price on shares of Cibus in a research report on Tuesday, October 22nd.

View Our Latest Report on CBUS

Cibus Stock Down 10.4 %

CBUS stock opened at $2.58 on Friday. Cibus, Inc. has a twelve month low of $2.35 and a twelve month high of $23.18. The company has a market cap of $68.26 million, a P/E ratio of -0.11 and a beta of 1.85. The business has a fifty day moving average of $3.87 and a 200-day moving average of $5.56.

About Cibus

(Free Report)

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.

Further Reading

Want to see what other hedge funds are holding CBUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cibus, Inc. (NASDAQ:CBUSFree Report).

Institutional Ownership by Quarter for Cibus (NASDAQ:CBUS)

Receive News & Ratings for Cibus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cibus and related companies with MarketBeat.com's FREE daily email newsletter.